Molecular characterisation of Babesia gibsoni infection from a Pit-bull terrier pup recently imported into South Africa
Author(s) -
P.T. Matjila,
B.L. Penzhorn,
Andrew L. Leisewitz,
Raksha Bhoora,
Robert H. Barker
Publication year - 2007
Publication title -
journal of the south african veterinary association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 31
eISSN - 2224-9435
pISSN - 1019-9128
DOI - 10.4102/jsava.v78i1.277
Subject(s) - atovaquone , babesiosis , babesia , azithromycin , veterinary medicine , virology , biology , diminazene , medicine , immunology , microbiology and biotechnology , malaria , trypanosomiasis , plasmodium falciparum , antibiotics
Canine babesiosis caused by Babesia gibsoni was diagnosed in a 3-month-old Pit-bull pup during a routine clinical examination. Diagnosis was confirmed by way of smear examination, PCR, Reverse Line Blot (RLB) and sequence analysis which showed 100% homology with B. gibsoni (Japan AB118032) and Babesia sp. (Oklahoma) (AF205636). Haematology showed moderate anaemia and severe thrombocytopenia. Treatment was initiated with diminazene aceturate (Berenil RTU) followed by 2 doses of imidocarb diproprionate (Forray-65) 3 days and 14 days later, respectively. Babesia gibsoni DNA was still detectable 2 weeks post-treatment on the PCR/RLB test. A 10-day course of combination drug therapy using atovaquone and azithromycin was initiated. Blood samples taken on Day 1 and Day 40 after completion of treatment were negative for B. gibsoni DNA on PCR/RLB test. The implications of a possible introduction of B. gibsoni into South Africa are discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom